Works matching IS 03057453 AND DT 2003 AND VI 51

Results: 276

Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients.

Published in:

2003

By:

Montecalvo, Marisa A

Publication type:

journal article

Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.

Published in:

2003

By:

Kauffman, Carol A

Publication type:

journal article

Clinical impact of vancomycin-resistant enterococci.

Published in:

2003

By:

Patel, Robin

Publication type:

journal article

European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 5, doi. 10.1093/jac/dkg271

By:

H. Goossens;
D. Jabes;
R. Rossi;
C. Lammens;
G. Privitera;
P. Courvalin

Publication type:

Article

Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 31, doi. 10.1093/jac/dkg274

By:

M.A. Montecalvo

Publication type:

Article

Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 23, doi. 10.1093/jac/dkg273

By:

C.A. Kauffman

Publication type:

Article

Clinical impact of vancomycin-resistant enterococci.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 13, doi. 10.1093/jac/dkg272

By:

R. Patel

Publication type:

Article

Preface.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 1, doi. 10.1093/jac/dkg310

By:

K. Kerr;
D. Reeves

Publication type:

Article

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1377

By:

Y. Mouton;
G.M. Bahr;
X. de La Tribonnière;
E. Darcissac;
F. Ajana;
L. Bocket;
D. Sissoko;
Y. Yazdanpanah;
J. Dewulf;
C. Amiel

Publication type:

Article

Improving the mouse model for studying the efficacy of voriconazole.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1373, doi. 10.1093/jac/dkg261

By:

J.R. Graybill;
L.K. Najvar;
G.M. Gonzalez;
S. Hernandez;
R. Bocanegra

Publication type:

Article

The bacteriocin piscicolin 126 retains antilisterial activity in vivo.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1365, doi. 10.1093/jac/dkg229

By:

A. Ingham;
M. Ford;
R.J. Moore;
M. Tizard

Publication type:

Article

Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1359, doi. 10.1093/jac/dkg258

By:

C. Faber;
H.P. Stallmann;
D.M. Lyaruu;
J.M.A. de Blieck;
T.J.M. Bervoets;
A. van Nieuw Amerongen;
P.I.J.M. Wuisman

Publication type:

Article

Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of β-lactamase expression in Aeromonas spp.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1351, doi. 10.1093/jac/dkg247

By:

P. Niumsup;
A.M. Simm;
K. Nurmahomed;
T.R. Walsh;
P.M. Bennett;
M.B. Avison

Publication type:

Article

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1339, doi. 10.1093/jac/dkg254

By:

C. Thomas;
M. Stevenson;
T.V. Riley

Publication type:

Article

Aromatic alcohols and their effect on Gram-negative bacteria, cocci and mycobacteria.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1435, doi. 10.1093/jac/dkg246

By:

S. Fraud;
E.L. Rees;
E. Mahenthiralingam;
A.D. Russell;
Maillard J.-Y.

Publication type:

Article

From evidence-based guideline methodology to quality of care standards.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1441, doi. 10.1093/jac/dkg324

By:

D. Nathwani

Publication type:

Article

In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time-kill.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1437, doi. 10.1093/jac/dkg263

By:

K.L. Credito;
M.R. Jacobs;
P.C. Appelbaum

Publication type:

Article

Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1436, doi. 10.1093/jac/dkg265

By:

A.A.F. Elsaghier;
J.S. Brazier;
E.A. James

Publication type:

Article

Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1327, doi. 10.1093/jac/dkg240

By:

B. Macchi;
E. Balestrieri;
A. Mastino

Publication type:

Article

Effects of antimicrobial therapy on the microbial flora of the adenoids.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1331, doi. 10.1093/jac/dkg260

By:

I. Brook

Publication type:

Article

Intrapulmonary penetration of linezolid.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1431, doi. 10.1093/jac/dkg262

By:

D. Honeybourne;
C. Tobin;
G. Jevons;
J. Andrews;
R. Wise

Publication type:

Article

Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1427, doi. 10.1093/jac/dkg230

By:

M.A. Hossain;
G.H. Reyes;
L.A. Long;
P.K. Mukherjee;
M.A. Ghannoum

Publication type:

Article

Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1423, doi. 10.1093/jac/dkg242

By:

E.K. Manavathu;
G.J. Alangaden;
P.H. Chandrasekar

Publication type:

Article

In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1419, doi. 10.1093/jac/dkg245

By:

N. Berthet;
O. Faure;
A. Bakri;
P. Ambroise-Thomas;
R. Grillot;
Brugère J.-F.

Publication type:

Article

Stretching the mutant prevention concentration (MPC) beyond its limits.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1323, doi. 10.1093/jac/dkg255

By:

H.J. Smith;
K.A. Nichol;
D.J. Hoban;
G.G. Zhanel

Publication type:

Article

Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-β-lactamase gene variants bla<sub>VIM-2</sub> and bla<sub>VIM-4</sub>.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1409, doi. 10.1093/jac/dkg239

By:

S. Pournaras;
M. Maniati;
E. Petinaki;
L.S. Tzouvelekis;
A. Tsakris;
N.J. Legakis;
A.N. Maniatis

Publication type:

Article

Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1403, doi. 10.1093/jac/dkg241

By:

D.J. Griggs;
H. Marona;
L.J.V. Piddock

Publication type:

Article

Molecular analysis of the plasmid-borne aacA/aphD resistance gene region of coagulase-negative staphylococci from chickens.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1397, doi. 10.1093/jac/dkg257

By:

C.C. Lange;
C. Werckenthin;
S. Schwarz

Publication type:

Article

Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1389, doi. 10.1093/jac/dkg264

By:

M.E.E. van Kasteren;
B.J. Kullberg;
A.S. de Boer;
J. Mintjes-de Groot;
I.C. Gyssens

Publication type:

Article

Activity of the amidoamine myristamidopropyl dimethylamine against keratitis pathogens.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 6, p. 1415, doi. 10.1093/jac/dkg259

By:

R. Hughes;
J. Dart;
S. Kilvington

Publication type:

Article

Preface.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii1
Publication type:: Article

Safety and tolerability of linezolid.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii45
Publication type:: Article

Introduction: treatment of Gram-positive infections.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii5
Publication type:: Article

Efficacy of linezolid versus comparator therapies in Gram-positive infections.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii27
Publication type:: Article

Linezolid in vitro: mechanism and antibacterial spectrum.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii9
Publication type:: Article

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. ii17
Publication type:: Article

The quinolones: decades of development and use.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 13, doi. 10.1093/jac/dkg208
Publication type:: Article

Preface.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. iii
Publication type:: Article

Development of the quinolones.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 1, doi. 10.1093/jac/dkg212
Publication type:: Article

Maximizing efficacy and reducing the emergence of resistance.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 37, doi. 10.1093/jac/dkg210
Publication type:: Article

Adverse drug reactions: implications for the development of fluoroquinolones.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 21, doi. 10.1093/jac/dkg209
Publication type:: Article

Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 37, doi. 10.1093/jac/dkg250

By:

D. Nathwani

Publication type:

Article

Nucleoside analogues and HIV: the combined cost to mitochondria.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1091, doi. 10.1093/jac/dkg203

By:

Catherine L. Cherry;
Steven L. Wesselingh

Publication type:

Article

Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 43, doi. 10.1093/jac/dkg211

By:

J.A. Paladino;
W.A. Callen

Publication type:

Article

Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1109, doi. 10.1093/jac/dkg222

By:

Joaquim Ruiz

Publication type:

Article

From evidence-based guideline methodology to quality of care standards.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1103, doi. 10.1093/jac/dkg243

By:

Dilip Nathwani

Publication type:

Article

Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1099, doi. 10.1093/jac/dkg214

By:

Marla J. Keller;
Mary E. Klotman;
Betsy C. Herold

Publication type:

Article

How does HAART lead to the resolution of Kaposi's sarcoma?

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1095, doi. 10.1093/jac/dkg199

By:

Justin Stebbing;
Simon Portsmouth;
Brian Gazzard

Publication type:

Article

Mechanisms of quinolone action and microbial response.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, p. 29, doi. 10.1093/jac/dkg207

By:

P.M. Hawkey

Publication type:

Article

Development of Novel Antimicrobial Agents: Emerging Strategies.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 51, n. 5, p. 1321, doi. 10.1093/jac/dkg182
Publication type:: Article